Anti-apoptotic protein Lifeguard does not act as a tumor marker in breast cancer


The aim of the present study was to use an enzyme-linked immunosorbent assay (ELISA) to determine the concentrations of Lifeguard (LFG) protein in the serum of 36 patients diagnosed with breast cancer and to compare these values with the concentrations of LFG protein in the serum of 7 healthy volunteers in order to detect a possible association between the… (More)
DOI: 10.3892/ol.2017.5658


16 Figures and Tables

Slides referencing similar topics